Novartis AG Market Cap 2006-2019 | NVS

Novartis AG market cap history and chart from 2006 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Novartis AG market cap as of February 19, 2020 is $222.76B.
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $222.763B $47.498B
Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership position in all of their businesses with a strong, sustainable performance based on continuous innovation. Their long-term success is founded on meeting the expectations of all our stakeholders - their customers, their people, their shareholders and the communities in which they live and work.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $392.517B 17.18
Roche Holding AG (RHHBY) Switzerland $301.984B 0.00
Merck (MRK) United States $209.942B 15.89
Pfizer (PFE) United States $200.999B 12.31
Novo Nordisk (NVO) Denmark $151.765B 26.05
AbbVie (ABBV) United States $138.432B 10.47
Eli Lilly (LLY) United States $135.388B 23.35
AstraZeneca (AZN) United Kingdom $128.853B 27.75
Sanofi (SNY) France $128.062B 15.22
GlaxoSmithKline (GSK) United Kingdom $108.669B 13.78
Bristol-Myers Squibb (BMY) United States $107.647B 14.15
Bayer (BAYRY) Germany $75.947B 11.25
H Lundbeck (HLUYY) Denmark $7.757B 13.48